Pennsylvania removes prior authorization for opioid treatment

| 3 Min Read

The Commonwealth of Pennsylvania and seven major health insurance companies agreed today to remove prior authorization requirements for treatment of substance use disorders, a move that has the potential to save thousands of lives, according to the American Medical Association (AMA) and Pennsylvania Medical Society.

In addition to removing this unnecessary restriction on treatment, insurers have also committed to including a comprehensive range of medications to treat substance use disorders on the lowest cost-sharing tier of a health plan’s pharmacy benefit as part of this agreement.

 

 

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read
General practitioner examining patient and hand

What doctors wish patients knew about rheumatoid arthritis

| 11 Min Read